NCT03363763 2025-12-01
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Aucta Pharmaceuticals, Inc
Phase 2 Terminated
Aucta Pharmaceuticals, Inc
Children's Hospital Medical Center, Cincinnati
Dermatology Specialties Limited Partnership
Dana-Farber Cancer Institute
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
The University of Texas Health Science Center, Houston
University of Pennsylvania